risks of glp-1 drugs & What They Do GLP-1 drugs may be doing

Our experience shows that the vast majority of issues reported by researchers stem not from the quality of the peptide itself, but from errors made during this crucial preparatory phase

They have significant dysbiosis

Patients with established heart disease should undergo comprehensive cardiovascular assessment before starting therapy, with particular attention to heart rate, blood pressure, and volume status

For example, although the tight control of synovial inflammation has proven to arrest the progression of bone erosions in some cases (for instance TNF- inhibitor has a promising effect on mitigating bone erosion in RA) 15 , the use of corticosteroids and MTX causes even more severe bone destruction in RA patients 16,17

One such approach that has garnered attention is the use of BPC 157 for arthritis

Beta-blockers are sometimes used if symptoms are very bothersome